Lumipulse^® G β2M-N (Beta 2-microglobulin)

Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of alpha-fetoprotein (AFP) in serum or plasma. The assay utilises proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.

Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of CA125 in serum or plasma.

For in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of CA15-3 in serum or plasma.

Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of CA19-9-N in serum or plasma.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of carcinoembryonic antigen (CEA) in serum or plasma.

Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of cytokeratin subunit 19 fragment (CYFRA) in serum or plasma.

Immunoreaction cartridges for in vitro diagnostics (IVD) use with the LUMIPULSE G System for the quantitative measurement of HE4 in human serum or plasma (sodium haparin, lithium heparin, or dipotassium EDTA) on the LUMIPULSE G System.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative determination Soluble Mesothelin Related Peptides (SMRP) in human serum or plasma.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of pepsinogen I in specimens based on CLEIA technology by two-step sandwich immunoassay method on the LUMIPULSE G system.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of pepsinogen Ⅱ in specimens based on CLEIA technology by two-step sandwich immunoassay on the LUMIPULSE G system.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of protein induced vitamin K absence or antagonist-II (PIVKA-II) in serum.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of Pro-gastrin-releasing peptide [ProGRP (31-98)] in serum or plasma.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of prostate specific antigen (PSA) in serum or plasma.